SCHEMBL991654

SCHEMBL991654

CCC(C)CCC[C](C)C

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.36
LMNA P02545 1/20 0.32
TSHR P16473 2/20 0.32
ACE2 Q9BYF1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9257324 0.95 PTPN1 (0.42) PTPN1LMNAACE2
SCHEMBL27481496 0.90 ACE2 (0.36) PTPN1LMNAACE2
SCHEMBL4620140 0.83
SCHEMBL28154748 0.82 ACE2 (0.42) PTPN1LMNATSHRACE2
SCHEMBL28161495 0.82 TSHR (0.46) PTPN1LMNATSHRACE2
SCHEMBL20228810 0.82 PTPN1 (0.35) PTPN1LMNATSHR
SCHEMBL1785759 0.80 ALDH1A1 (0.41) PTPN1LMNAACE2
SCHEMBL1296286 0.80 PTPN1 (0.34) PTPN1
SCHEMBL28309634 0.80 PTPN1 (0.34) PTPN1
SCHEMBL11819776 0.80 PTPN1 (0.34) PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024112938-A1 NEW METHOD FOR THE OZONOLYTIC SYNTHESIS OF HIGH MELTING DICARBOXYLIC ACIDS AND OXO-ACIDS P2 SCIENCE, INC. (US) 2024-05-30 WO claimed
EP-4341325-A1 TERPENE ESTER SURFACTANTS P2 Science, Inc. (US) 2024-03-27 EP claimed
EP-4341381-A1 TERPENOL ETHERS P2 Science, Inc. (US) 2024-03-27 EP claimed
EP-4341380-A1 FATTY ACID TERPENE ALCOHOL ESTERS P2 Science, Inc. (US) 2024-03-27 EP claimed
US-20220380678-A1 TERPENE ESTER SURFACTANTS P2 SCIENCE, INC. 2022-12-01 US claimed
US-20220380290-A1 ARYL TERPENE ESTERS P2 SCIENCE, INC. 2022-12-01 US claimed
WO-2022245837-A1 TERPENE ESTER SURFACTANTS P2S SCIENCE, INC. (US) 2022-11-24 WO claimed
US-10202322-B2 Resorcinol derivatives SUTTER BAY HOSPITALS (US) 2019-02-12 US claimed
WO-2018145219-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING SERANI MOSTAZAL JORGE (CL) 2018-08-16 WO claimed
US-20180170846-A1 RESORCINOL DERIVATIVES SUTTER WEST BAY HOSPITALS 2018-06-21 US claimed
US-20130209483-A1 CANNABIDINOID DERIVATIVES SUTTER WEST BAY HOSPITALS (US) 2013-08-15 US claimed
WO-2009131692-A1 SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2009-10-29 WO claimed
CN-1232515-C Reworkable composition of ethylene oxide or thiirane containing resin and curing agent HENKEL CORP (US) 2005-12-21 CN claimed
US-4138259-A Color photographic light-sensitive material FUJI PHOTO FILM CO., LTD. (JP) 1979-02-06 US claimed
WO-2024112938-A1 NEW METHOD FOR THE OZONOLYTIC SYNTHESIS OF HIGH MELTING DICARBOXYLIC ACIDS AND OXO-ACIDS P2 SCIENCE, INC. (US) 2024-05-30 WO disclosed
EP-4341381-A1 TERPENOL ETHERS P2 Science, Inc. (US) 2024-03-27 EP disclosed
EP-4341380-A1 FATTY ACID TERPENE ALCOHOL ESTERS P2 Science, Inc. (US) 2024-03-27 EP disclosed
WO-1998006803-A1 RINSE ADDED FABRIC SOFTENING COMPOSITIONS AND METHOD OF USE FOR THE DELIVERY OF FRAGRANCE PRECURSORS THE PROCTER & GAMBLE COMPANY (US) 1998-02-19 WO disclosed
US-4138259-A Color photographic light-sensitive material FUJI PHOTO FILM CO., LTD. (JP) 1979-02-06 US disclosed
US-4121939-A Color photographic light-sensitive material containing +-alkyl substituted hydroquinone FUJI PHOTO FILM CO., LTD. (JP) 1978-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220380678-A1 TERPENE ESTER SURFACTANTS EBP, CETP, LSS PTPN1 3988/4885LMNA 2508/4885TSHR 3446/4885
US-10202322-B2 Resorcinol derivatives CNR1, CNR2, RCOR1 PTPN1 2991/4885LMNA 3370/4885TSHR 3290/4885
US-20220380290-A1 ARYL TERPENE ESTERS EBP, CYP4A11, LSS PTPN1 3641/4885LMNA 2885/4885TSHR 2107/4885
US-20130209483-A1 CANNABIDINOID DERIVATIVES CNR2, CNR1, GPR18 PTPN1 3988/4885LMNA 2282/4885TSHR 4095/4885
US-20180170846-A1 RESORCINOL DERIVATIVES CNR1, CNR2, RCOR1 PTPN1 2991/4885LMNA 3370/4885TSHR 3290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.